nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—Crohn's disease—colon cancer	0.344	0.585	CtDrD
Prednisone—ulcerative colitis—colon cancer	0.243	0.415	CtDrD
Prednisone—ABCB1—colon cancer	0.186	1	CbGaD
Prednisone—SLCO1A2—Methotrexate—colon cancer	0.0275	0.191	CbGbCtD
Prednisone—ALB—Irinotecan—colon cancer	0.0268	0.187	CbGbCtD
Prednisone—ALB—Fluorouracil—colon cancer	0.0258	0.179	CbGbCtD
Prednisone—ALB—Methotrexate—colon cancer	0.0142	0.0988	CbGbCtD
Prednisone—ABCB1—Irinotecan—colon cancer	0.014	0.0976	CbGbCtD
Prednisone—ABCB1—Vincristine—colon cancer	0.0123	0.0853	CbGbCtD
Prednisone—CYP3A4—Irinotecan—colon cancer	0.00841	0.0585	CbGbCtD
Prednisone—ABCB1—Methotrexate—colon cancer	0.00743	0.0517	CbGbCtD
Prednisone—CYP3A4—Vincristine—colon cancer	0.00735	0.0511	CbGbCtD
Prednisone—HSD11B1—smooth muscle tissue—colon cancer	0.00169	0.115	CbGeAlD
Prednisone—HSD11B1—renal system—colon cancer	0.00163	0.111	CbGeAlD
Prednisone—HSD11B1—vagina—colon cancer	0.00118	0.0802	CbGeAlD
Prednisone—ALB—gall bladder—colon cancer	0.00102	0.0694	CbGeAlD
Prednisone—HSD11B1—liver—colon cancer	0.000994	0.0676	CbGeAlD
Prednisone—HSD11B1—lymph node—colon cancer	0.000762	0.0519	CbGeAlD
Prednisone—SLCO1A2—renal system—colon cancer	0.000492	0.0335	CbGeAlD
Prednisone—NR3C1—embryo—colon cancer	0.000407	0.0277	CbGeAlD
Prednisone—SLCO1A2—digestive system—colon cancer	0.000403	0.0275	CbGeAlD
Prednisone—ABCB1—blood vessel—colon cancer	0.000365	0.0248	CbGeAlD
Prednisone—NR3C1—epithelium—colon cancer	0.000332	0.0226	CbGeAlD
Prednisone—CYP2C19—digestive system—colon cancer	0.000323	0.022	CbGeAlD
Prednisone—NR3C1—smooth muscle tissue—colon cancer	0.00032	0.0218	CbGeAlD
Prednisone—NR3C1—renal system—colon cancer	0.000308	0.021	CbGeAlD
Prednisone—SLCO1A2—liver—colon cancer	0.000301	0.0205	CbGeAlD
Prednisone—ALB—liver—colon cancer	0.000299	0.0203	CbGeAlD
Prednisone—CYP2C19—vagina—colon cancer	0.000285	0.0194	CbGeAlD
Prednisone—NR3C1—lymphoid tissue—colon cancer	0.000256	0.0174	CbGeAlD
Prednisone—NR3C1—digestive system—colon cancer	0.000252	0.0172	CbGeAlD
Prednisone—CYP2C19—liver—colon cancer	0.000241	0.0164	CbGeAlD
Prednisone—CYP3A4—renal system—colon cancer	0.000233	0.0158	CbGeAlD
Prednisone—NR3C1—bone marrow—colon cancer	0.000233	0.0158	CbGeAlD
Prednisone—ALB—lymph node—colon cancer	0.000229	0.0156	CbGeAlD
Prednisone—NR3C1—vagina—colon cancer	0.000223	0.0152	CbGeAlD
Prednisone—ABCB1—embryo—colon cancer	0.000218	0.0148	CbGeAlD
Prednisone—CYP3A4—digestive system—colon cancer	0.000191	0.013	CbGeAlD
Prednisone—NR3C1—liver—colon cancer	0.000188	0.0128	CbGeAlD
Prednisone—ABCB1—epithelium—colon cancer	0.000178	0.0121	CbGeAlD
Prednisone—Bradycardia—Irinotecan—colon cancer	0.000168	0.00246	CcSEcCtD
Prednisone—Vasculitis—Methotrexate—colon cancer	0.000168	0.00246	CcSEcCtD
Prednisone—Connective tissue disorder—Vincristine—colon cancer	0.000167	0.00244	CcSEcCtD
Prednisone—Haemoglobin—Irinotecan—colon cancer	0.000166	0.00243	CcSEcCtD
Prednisone—Purpura—Capecitabine—colon cancer	0.000166	0.00243	CcSEcCtD
Prednisone—Haemorrhage—Irinotecan—colon cancer	0.000165	0.00242	CcSEcCtD
Prednisone—ABCB1—renal system—colon cancer	0.000165	0.0112	CbGeAlD
Prednisone—Cardiac failure—Capecitabine—colon cancer	0.000164	0.0024	CcSEcCtD
Prednisone—Lethargy—Capecitabine—colon cancer	0.000163	0.00239	CcSEcCtD
Prednisone—Connective tissue disorder—Irinotecan—colon cancer	0.000162	0.00238	CcSEcCtD
Prednisone—Osteoarthritis—Capecitabine—colon cancer	0.00016	0.00234	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00016	0.00234	CcSEcCtD
Prednisone—Haemoglobin—Fluorouracil—colon cancer	0.000159	0.00233	CcSEcCtD
Prednisone—Haemorrhage—Fluorouracil—colon cancer	0.000158	0.00232	CcSEcCtD
Prednisone—Skin exfoliation—Methotrexate—colon cancer	0.000156	0.00229	CcSEcCtD
Prednisone—Face oedema—Capecitabine—colon cancer	0.000154	0.00226	CcSEcCtD
Prednisone—Angiopathy—Vincristine—colon cancer	0.000154	0.00226	CcSEcCtD
Prednisone—Flushing—Irinotecan—colon cancer	0.000153	0.00225	CcSEcCtD
Prednisone—Irritability—Capecitabine—colon cancer	0.000153	0.00224	CcSEcCtD
Prednisone—Cardiac arrest—Capecitabine—colon cancer	0.000152	0.00223	CcSEcCtD
Prednisone—Mood swings—Capecitabine—colon cancer	0.000151	0.00222	CcSEcCtD
Prednisone—Alopecia—Vincristine—colon cancer	0.00015	0.0022	CcSEcCtD
Prednisone—Angiopathy—Irinotecan—colon cancer	0.00015	0.0022	CcSEcCtD
Prednisone—Immune system disorder—Irinotecan—colon cancer	0.000149	0.00219	CcSEcCtD
Prednisone—Mental disorder—Vincristine—colon cancer	0.000149	0.00218	CcSEcCtD
Prednisone—Ecchymosis—Methotrexate—colon cancer	0.000148	0.00217	CcSEcCtD
Prednisone—Arrhythmia—Irinotecan—colon cancer	0.000148	0.00216	CcSEcCtD
Prednisone—Dry skin—Capecitabine—colon cancer	0.000146	0.00215	CcSEcCtD
Prednisone—Alopecia—Irinotecan—colon cancer	0.000146	0.00214	CcSEcCtD
Prednisone—Pulmonary oedema—Methotrexate—colon cancer	0.000146	0.00214	CcSEcCtD
Prednisone—Hypokalaemia—Capecitabine—colon cancer	0.000145	0.00213	CcSEcCtD
Prednisone—NR3C1—lymph node—colon cancer	0.000144	0.00982	CbGeAlD
Prednisone—CYP3A4—liver—colon cancer	0.000142	0.00968	CbGeAlD
Prednisone—Sepsis—Methotrexate—colon cancer	0.000142	0.00208	CcSEcCtD
Prednisone—Arrhythmia—Fluorouracil—colon cancer	0.000141	0.00207	CcSEcCtD
Prednisone—Muscular weakness—Capecitabine—colon cancer	0.000141	0.00207	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000141	0.00207	CcSEcCtD
Prednisone—Alopecia—Fluorouracil—colon cancer	0.00014	0.00205	CcSEcCtD
Prednisone—Abdominal distension—Capecitabine—colon cancer	0.000139	0.00204	CcSEcCtD
Prednisone—Erythema—Fluorouracil—colon cancer	0.000138	0.00202	CcSEcCtD
Prednisone—Thrombophlebitis—Methotrexate—colon cancer	0.000137	0.00201	CcSEcCtD
Prednisone—ABCB1—lymphoid tissue—colon cancer	0.000137	0.00931	CbGeAlD
Prednisone—Diabetes mellitus—Methotrexate—colon cancer	0.000137	0.002	CcSEcCtD
Prednisone—Anaemia—Vincristine—colon cancer	0.000136	0.002	CcSEcCtD
Prednisone—Agitation—Vincristine—colon cancer	0.000136	0.00199	CcSEcCtD
Prednisone—ABCB1—digestive system—colon cancer	0.000135	0.0092	CbGeAlD
Prednisone—Sweating increased—Capecitabine—colon cancer	0.000135	0.00197	CcSEcCtD
Prednisone—Ill-defined disorder—Irinotecan—colon cancer	0.000133	0.00196	CcSEcCtD
Prednisone—Anaemia—Irinotecan—colon cancer	0.000133	0.00195	CcSEcCtD
Prednisone—Vertigo—Vincristine—colon cancer	0.000133	0.00194	CcSEcCtD
Prednisone—Vision blurred—Fluorouracil—colon cancer	0.00013	0.0019	CcSEcCtD
Prednisone—Malaise—Irinotecan—colon cancer	0.00013	0.0019	CcSEcCtD
Prednisone—Vertigo—Irinotecan—colon cancer	0.000129	0.00189	CcSEcCtD
Prednisone—Neutropenia—Capecitabine—colon cancer	0.000129	0.00189	CcSEcCtD
Prednisone—Syncope—Irinotecan—colon cancer	0.000129	0.00189	CcSEcCtD
Prednisone—Convulsion—Vincristine—colon cancer	0.000128	0.00187	CcSEcCtD
Prednisone—Hypertension—Vincristine—colon cancer	0.000127	0.00187	CcSEcCtD
Prednisone—Anaemia—Fluorouracil—colon cancer	0.000127	0.00187	CcSEcCtD
Prednisone—Loss of consciousness—Irinotecan—colon cancer	0.000126	0.00185	CcSEcCtD
Prednisone—Myalgia—Vincristine—colon cancer	0.000126	0.00184	CcSEcCtD
Prednisone—Weight increased—Capecitabine—colon cancer	0.000126	0.00184	CcSEcCtD
Prednisone—Weight decreased—Capecitabine—colon cancer	0.000125	0.00183	CcSEcCtD
Prednisone—Hyperglycaemia—Capecitabine—colon cancer	0.000125	0.00183	CcSEcCtD
Prednisone—ABCB1—bone marrow—colon cancer	0.000125	0.00848	CbGeAlD
Prednisone—Hypertension—Irinotecan—colon cancer	0.000124	0.00182	CcSEcCtD
Prednisone—Depression—Capecitabine—colon cancer	0.000123	0.0018	CcSEcCtD
Prednisone—Acute coronary syndrome—Capecitabine—colon cancer	0.000121	0.00178	CcSEcCtD
Prednisone—Lethargy—Methotrexate—colon cancer	0.000121	0.00178	CcSEcCtD
Prednisone—Discomfort—Irinotecan—colon cancer	0.000121	0.00177	CcSEcCtD
Prednisone—Neuropathy peripheral—Capecitabine—colon cancer	0.000121	0.00177	CcSEcCtD
Prednisone—Myocardial infarction—Capecitabine—colon cancer	0.000121	0.00177	CcSEcCtD
Prednisone—Anaphylactic shock—Vincristine—colon cancer	0.000121	0.00177	CcSEcCtD
Prednisone—Oedema—Vincristine—colon cancer	0.000121	0.00177	CcSEcCtD
Prednisone—Infection—Vincristine—colon cancer	0.00012	0.00175	CcSEcCtD
Prednisone—ABCB1—vagina—colon cancer	0.000119	0.00812	CbGeAlD
Prednisone—Convulsion—Fluorouracil—colon cancer	0.000119	0.00175	CcSEcCtD
Prednisone—Osteoarthritis—Methotrexate—colon cancer	0.000119	0.00174	CcSEcCtD
Prednisone—Nervous system disorder—Vincristine—colon cancer	0.000118	0.00173	CcSEcCtD
Prednisone—Anaphylactic shock—Irinotecan—colon cancer	0.000117	0.00172	CcSEcCtD
Prednisone—Oedema—Irinotecan—colon cancer	0.000117	0.00172	CcSEcCtD
Prednisone—Myalgia—Fluorouracil—colon cancer	0.000117	0.00172	CcSEcCtD
Prednisone—Infection—Irinotecan—colon cancer	0.000117	0.00171	CcSEcCtD
Prednisone—Hyperhidrosis—Vincristine—colon cancer	0.000117	0.00171	CcSEcCtD
Prednisone—Discomfort—Fluorouracil—colon cancer	0.000116	0.0017	CcSEcCtD
Prednisone—Shock—Irinotecan—colon cancer	0.000115	0.00169	CcSEcCtD
Prednisone—Nervous system disorder—Irinotecan—colon cancer	0.000115	0.00169	CcSEcCtD
Prednisone—Anorexia—Vincristine—colon cancer	0.000115	0.00168	CcSEcCtD
Prednisone—Irritability—Methotrexate—colon cancer	0.000114	0.00166	CcSEcCtD
Prednisone—Hyperhidrosis—Irinotecan—colon cancer	0.000113	0.00166	CcSEcCtD
Prednisone—Mood swings—Methotrexate—colon cancer	0.000113	0.00165	CcSEcCtD
Prednisone—Bradycardia—Capecitabine—colon cancer	0.000113	0.00165	CcSEcCtD
Prednisone—Anaphylactic shock—Fluorouracil—colon cancer	0.000112	0.00165	CcSEcCtD
Prednisone—Oedema—Fluorouracil—colon cancer	0.000112	0.00165	CcSEcCtD
Prednisone—Anorexia—Irinotecan—colon cancer	0.000112	0.00164	CcSEcCtD
Prednisone—Infection—Fluorouracil—colon cancer	0.000112	0.00164	CcSEcCtD
Prednisone—Haemoglobin—Capecitabine—colon cancer	0.000111	0.00163	CcSEcCtD
Prednisone—Haemorrhage—Capecitabine—colon cancer	0.000111	0.00162	CcSEcCtD
Prednisone—Nervous system disorder—Fluorouracil—colon cancer	0.00011	0.00162	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00011	0.00161	CcSEcCtD
Prednisone—Tachycardia—Fluorouracil—colon cancer	0.00011	0.00161	CcSEcCtD
Prednisone—Insomnia—Vincristine—colon cancer	0.000109	0.0016	CcSEcCtD
Prednisone—Connective tissue disorder—Capecitabine—colon cancer	0.000109	0.00159	CcSEcCtD
Prednisone—Paraesthesia—Vincristine—colon cancer	0.000108	0.00159	CcSEcCtD
Prednisone—Anorexia—Fluorouracil—colon cancer	0.000107	0.00157	CcSEcCtD
Prednisone—Insomnia—Irinotecan—colon cancer	0.000106	0.00156	CcSEcCtD
Prednisone—Paraesthesia—Irinotecan—colon cancer	0.000105	0.00154	CcSEcCtD
Prednisone—Decreased appetite—Vincristine—colon cancer	0.000105	0.00154	CcSEcCtD
Prednisone—Fatigue—Vincristine—colon cancer	0.000104	0.00152	CcSEcCtD
Prednisone—Eye disorder—Capecitabine—colon cancer	0.000103	0.00151	CcSEcCtD
Prednisone—Dyspepsia—Irinotecan—colon cancer	0.000103	0.00151	CcSEcCtD
Prednisone—Constipation—Vincristine—colon cancer	0.000103	0.00151	CcSEcCtD
Prednisone—Flushing—Capecitabine—colon cancer	0.000103	0.0015	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000102	0.0015	CcSEcCtD
Prednisone—Decreased appetite—Irinotecan—colon cancer	0.000102	0.0015	CcSEcCtD
Prednisone—Insomnia—Fluorouracil—colon cancer	0.000102	0.00149	CcSEcCtD
Prednisone—Fatigue—Irinotecan—colon cancer	0.000101	0.00148	CcSEcCtD
Prednisone—Paraesthesia—Fluorouracil—colon cancer	0.000101	0.00148	CcSEcCtD
Prednisone—Pancreatitis—Methotrexate—colon cancer	0.000101	0.00148	CcSEcCtD
Prednisone—ABCB1—liver—colon cancer	0.000101	0.00685	CbGeAlD
Prednisone—Constipation—Irinotecan—colon cancer	0.0001	0.00147	CcSEcCtD
Prednisone—Angiopathy—Capecitabine—colon cancer	0.0001	0.00147	CcSEcCtD
Prednisone—Immune system disorder—Capecitabine—colon cancer	9.99e-05	0.00146	CcSEcCtD
Prednisone—Dyspepsia—Fluorouracil—colon cancer	9.89e-05	0.00145	CcSEcCtD
Prednisone—Arrhythmia—Capecitabine—colon cancer	9.88e-05	0.00145	CcSEcCtD
Prednisone—Gastrointestinal pain—Vincristine—colon cancer	9.85e-05	0.00144	CcSEcCtD
Prednisone—Decreased appetite—Fluorouracil—colon cancer	9.77e-05	0.00143	CcSEcCtD
Prednisone—Alopecia—Capecitabine—colon cancer	9.77e-05	0.00143	CcSEcCtD
Prednisone—Mental disorder—Capecitabine—colon cancer	9.69e-05	0.00142	CcSEcCtD
Prednisone—Feeling abnormal—Irinotecan—colon cancer	9.67e-05	0.00142	CcSEcCtD
Prednisone—Malnutrition—Capecitabine—colon cancer	9.62e-05	0.00141	CcSEcCtD
Prednisone—Erythema—Capecitabine—colon cancer	9.62e-05	0.00141	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—colon cancer	9.62e-05	0.00141	CcSEcCtD
Prednisone—Gastrointestinal pain—Irinotecan—colon cancer	9.6e-05	0.00141	CcSEcCtD
Prednisone—Abdominal pain—Vincristine—colon cancer	9.53e-05	0.0014	CcSEcCtD
Prednisone—Body temperature increased—Vincristine—colon cancer	9.53e-05	0.0014	CcSEcCtD
Prednisone—Methylprednisolone—ABCB1—colon cancer	9.48e-05	0.178	CrCbGaD
Prednisone—Erectile dysfunction—Methotrexate—colon cancer	9.47e-05	0.00139	CcSEcCtD
Prednisone—Triamcinolone—PTGS2—colon cancer	9.4e-05	0.177	CrCbGaD
Prednisone—Abdominal pain—Irinotecan—colon cancer	9.28e-05	0.00136	CcSEcCtD
Prednisone—Body temperature increased—Irinotecan—colon cancer	9.28e-05	0.00136	CcSEcCtD
Prednisone—Feeling abnormal—Fluorouracil—colon cancer	9.26e-05	0.00136	CcSEcCtD
Prednisone—Depression—Methotrexate—colon cancer	9.14e-05	0.00134	CcSEcCtD
Prednisone—Vision blurred—Capecitabine—colon cancer	9.07e-05	0.00133	CcSEcCtD
Prednisone—Ill-defined disorder—Capecitabine—colon cancer	8.93e-05	0.00131	CcSEcCtD
Prednisone—Urticaria—Fluorouracil—colon cancer	8.93e-05	0.00131	CcSEcCtD
Prednisone—Anaemia—Capecitabine—colon cancer	8.9e-05	0.0013	CcSEcCtD
Prednisone—Body temperature increased—Fluorouracil—colon cancer	8.89e-05	0.0013	CcSEcCtD
Prednisone—Hypersensitivity—Vincristine—colon cancer	8.88e-05	0.0013	CcSEcCtD
Prednisone—Malaise—Capecitabine—colon cancer	8.68e-05	0.00127	CcSEcCtD
Prednisone—Vertigo—Capecitabine—colon cancer	8.65e-05	0.00127	CcSEcCtD
Prednisone—Hypersensitivity—Irinotecan—colon cancer	8.65e-05	0.00127	CcSEcCtD
Prednisone—Asthenia—Vincristine—colon cancer	8.65e-05	0.00127	CcSEcCtD
Prednisone—Syncope—Capecitabine—colon cancer	8.63e-05	0.00126	CcSEcCtD
Prednisone—Loss of consciousness—Capecitabine—colon cancer	8.46e-05	0.00124	CcSEcCtD
Prednisone—Asthenia—Irinotecan—colon cancer	8.42e-05	0.00123	CcSEcCtD
Prednisone—Hypertension—Capecitabine—colon cancer	8.31e-05	0.00122	CcSEcCtD
Prednisone—Hypersensitivity—Fluorouracil—colon cancer	8.28e-05	0.00121	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—colon cancer	8.27e-05	0.00121	CcSEcCtD
Prednisone—Diarrhoea—Vincristine—colon cancer	8.25e-05	0.00121	CcSEcCtD
Prednisone—Haemorrhage—Methotrexate—colon cancer	8.23e-05	0.00121	CcSEcCtD
Prednisone—Arthralgia—Capecitabine—colon cancer	8.19e-05	0.0012	CcSEcCtD
Prednisone—Myalgia—Capecitabine—colon cancer	8.19e-05	0.0012	CcSEcCtD
Prednisone—Anxiety—Capecitabine—colon cancer	8.17e-05	0.0012	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	8.14e-05	0.00119	CcSEcCtD
Prednisone—Discomfort—Capecitabine—colon cancer	8.1e-05	0.00119	CcSEcCtD
Prednisone—Diarrhoea—Irinotecan—colon cancer	8.03e-05	0.00118	CcSEcCtD
Prednisone—Dizziness—Vincristine—colon cancer	7.97e-05	0.00117	CcSEcCtD
Prednisone—Pruritus—Fluorouracil—colon cancer	7.95e-05	0.00117	CcSEcCtD
Prednisone—Oedema—Capecitabine—colon cancer	7.86e-05	0.00115	CcSEcCtD
Prednisone—Infection—Capecitabine—colon cancer	7.8e-05	0.00114	CcSEcCtD
Prednisone—Dizziness—Irinotecan—colon cancer	7.76e-05	0.00114	CcSEcCtD
Prednisone—Shock—Capecitabine—colon cancer	7.73e-05	0.00113	CcSEcCtD
Prednisone—ABCB1—lymph node—colon cancer	7.72e-05	0.00526	CbGeAlD
Prednisone—Nervous system disorder—Capecitabine—colon cancer	7.7e-05	0.00113	CcSEcCtD
Prednisone—Betamethasone—PTGS2—colon cancer	7.7e-05	0.145	CrCbGaD
Prednisone—Eye disorder—Methotrexate—colon cancer	7.69e-05	0.00113	CcSEcCtD
Prednisone—Diarrhoea—Fluorouracil—colon cancer	7.69e-05	0.00113	CcSEcCtD
Prednisone—Tachycardia—Capecitabine—colon cancer	7.67e-05	0.00112	CcSEcCtD
Prednisone—Vomiting—Vincristine—colon cancer	7.66e-05	0.00112	CcSEcCtD
Prednisone—Skin disorder—Capecitabine—colon cancer	7.63e-05	0.00112	CcSEcCtD
Prednisone—Rash—Vincristine—colon cancer	7.6e-05	0.00111	CcSEcCtD
Prednisone—Hyperhidrosis—Capecitabine—colon cancer	7.59e-05	0.00111	CcSEcCtD
Prednisone—Dermatitis—Vincristine—colon cancer	7.59e-05	0.00111	CcSEcCtD
Prednisone—Headache—Vincristine—colon cancer	7.55e-05	0.00111	CcSEcCtD
Prednisone—Anorexia—Capecitabine—colon cancer	7.49e-05	0.0011	CcSEcCtD
Prednisone—Angiopathy—Methotrexate—colon cancer	7.47e-05	0.00109	CcSEcCtD
Prednisone—Vomiting—Irinotecan—colon cancer	7.46e-05	0.00109	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—colon cancer	7.43e-05	0.00109	CcSEcCtD
Prednisone—Dizziness—Fluorouracil—colon cancer	7.43e-05	0.00109	CcSEcCtD
Prednisone—Rash—Irinotecan—colon cancer	7.4e-05	0.00108	CcSEcCtD
Prednisone—Dermatitis—Irinotecan—colon cancer	7.39e-05	0.00108	CcSEcCtD
Prednisone—Headache—Irinotecan—colon cancer	7.35e-05	0.00108	CcSEcCtD
Prednisone—Alopecia—Methotrexate—colon cancer	7.27e-05	0.00107	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—colon cancer	7.21e-05	0.00106	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—colon cancer	7.16e-05	0.00105	CcSEcCtD
Prednisone—Erythema—Methotrexate—colon cancer	7.16e-05	0.00105	CcSEcCtD
Prednisone—Nausea—Vincristine—colon cancer	7.16e-05	0.00105	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Capecitabine—colon cancer	7.16e-05	0.00105	CcSEcCtD
Prednisone—Vomiting—Fluorouracil—colon cancer	7.15e-05	0.00105	CcSEcCtD
Prednisone—Insomnia—Capecitabine—colon cancer	7.1e-05	0.00104	CcSEcCtD
Prednisone—Rash—Fluorouracil—colon cancer	7.09e-05	0.00104	CcSEcCtD
Prednisone—Dermatitis—Fluorouracil—colon cancer	7.08e-05	0.00104	CcSEcCtD
Prednisone—Paraesthesia—Capecitabine—colon cancer	7.05e-05	0.00103	CcSEcCtD
Prednisone—Headache—Fluorouracil—colon cancer	7.04e-05	0.00103	CcSEcCtD
Prednisone—Nausea—Irinotecan—colon cancer	6.97e-05	0.00102	CcSEcCtD
Prednisone—Dyspepsia—Capecitabine—colon cancer	6.91e-05	0.00101	CcSEcCtD
Prednisone—Decreased appetite—Capecitabine—colon cancer	6.83e-05	0.001	CcSEcCtD
Prednisone—Fatigue—Capecitabine—colon cancer	6.77e-05	0.000993	CcSEcCtD
Prednisone—Vision blurred—Methotrexate—colon cancer	6.75e-05	0.00099	CcSEcCtD
Prednisone—Constipation—Capecitabine—colon cancer	6.72e-05	0.000984	CcSEcCtD
Prednisone—Prednisolone—ABCB1—colon cancer	6.68e-05	0.126	CrCbGaD
Prednisone—Nausea—Fluorouracil—colon cancer	6.68e-05	0.000979	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—colon cancer	6.65e-05	0.000974	CcSEcCtD
Prednisone—Anaemia—Methotrexate—colon cancer	6.62e-05	0.000971	CcSEcCtD
Prednisone—Betamethasone—ABCB1—colon cancer	6.54e-05	0.123	CrCbGaD
Prednisone—Feeling abnormal—Capecitabine—colon cancer	6.47e-05	0.000949	CcSEcCtD
Prednisone—Malaise—Methotrexate—colon cancer	6.46e-05	0.000947	CcSEcCtD
Prednisone—Vertigo—Methotrexate—colon cancer	6.44e-05	0.000943	CcSEcCtD
Prednisone—Gastrointestinal pain—Capecitabine—colon cancer	6.42e-05	0.000941	CcSEcCtD
Prednisone—Urticaria—Capecitabine—colon cancer	6.24e-05	0.000915	CcSEcCtD
Prednisone—Body temperature increased—Capecitabine—colon cancer	6.21e-05	0.00091	CcSEcCtD
Prednisone—Abdominal pain—Capecitabine—colon cancer	6.21e-05	0.00091	CcSEcCtD
Prednisone—Convulsion—Methotrexate—colon cancer	6.21e-05	0.00091	CcSEcCtD
Prednisone—Arthralgia—Methotrexate—colon cancer	6.1e-05	0.000894	CcSEcCtD
Prednisone—Myalgia—Methotrexate—colon cancer	6.1e-05	0.000894	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	6.06e-05	0.000888	CcSEcCtD
Prednisone—Discomfort—Methotrexate—colon cancer	6.03e-05	0.000883	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—colon cancer	5.85e-05	0.000857	CcSEcCtD
Prednisone—Infection—Methotrexate—colon cancer	5.81e-05	0.000851	CcSEcCtD
Prednisone—Hypersensitivity—Capecitabine—colon cancer	5.79e-05	0.000848	CcSEcCtD
Prednisone—Nervous system disorder—Methotrexate—colon cancer	5.73e-05	0.00084	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—colon cancer	5.68e-05	0.000832	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—colon cancer	5.65e-05	0.000828	CcSEcCtD
Prednisone—Asthenia—Capecitabine—colon cancer	5.64e-05	0.000826	CcSEcCtD
Prednisone—Anorexia—Methotrexate—colon cancer	5.57e-05	0.000817	CcSEcCtD
Prednisone—Pruritus—Capecitabine—colon cancer	5.56e-05	0.000814	CcSEcCtD
Prednisone—Diarrhoea—Capecitabine—colon cancer	5.37e-05	0.000788	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—colon cancer	5.33e-05	0.000781	CcSEcCtD
Prednisone—Insomnia—Methotrexate—colon cancer	5.29e-05	0.000775	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—colon cancer	5.25e-05	0.00077	CcSEcCtD
Prednisone—Dizziness—Capecitabine—colon cancer	5.19e-05	0.000761	CcSEcCtD
Prednisone—Dyspepsia—Methotrexate—colon cancer	5.15e-05	0.000754	CcSEcCtD
Prednisone—Hydrocortisone—ABCB1—colon cancer	5.11e-05	0.0961	CrCbGaD
Prednisone—Decreased appetite—Methotrexate—colon cancer	5.08e-05	0.000745	CcSEcCtD
Prednisone—Fatigue—Methotrexate—colon cancer	5.04e-05	0.000739	CcSEcCtD
Prednisone—Vomiting—Capecitabine—colon cancer	4.99e-05	0.000732	CcSEcCtD
Prednisone—Rash—Capecitabine—colon cancer	4.95e-05	0.000726	CcSEcCtD
Prednisone—Dermatitis—Capecitabine—colon cancer	4.95e-05	0.000725	CcSEcCtD
Prednisone—Headache—Capecitabine—colon cancer	4.92e-05	0.000721	CcSEcCtD
Prednisone—Feeling abnormal—Methotrexate—colon cancer	4.82e-05	0.000706	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—colon cancer	4.78e-05	0.000701	CcSEcCtD
Prednisone—Nausea—Capecitabine—colon cancer	4.67e-05	0.000684	CcSEcCtD
Prednisone—Urticaria—Methotrexate—colon cancer	4.65e-05	0.000681	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—colon cancer	4.62e-05	0.000677	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—colon cancer	4.62e-05	0.000677	CcSEcCtD
Prednisone—Dexamethasone—PTGS2—colon cancer	4.48e-05	0.0842	CrCbGaD
Prednisone—Hypersensitivity—Methotrexate—colon cancer	4.31e-05	0.000631	CcSEcCtD
Prednisone—Asthenia—Methotrexate—colon cancer	4.2e-05	0.000615	CcSEcCtD
Prednisone—Pruritus—Methotrexate—colon cancer	4.14e-05	0.000606	CcSEcCtD
Prednisone—Diarrhoea—Methotrexate—colon cancer	4e-05	0.000586	CcSEcCtD
Prednisone—Dizziness—Methotrexate—colon cancer	3.87e-05	0.000567	CcSEcCtD
Prednisone—Dexamethasone—ABCB1—colon cancer	3.81e-05	0.0716	CrCbGaD
Prednisone—Vomiting—Methotrexate—colon cancer	3.72e-05	0.000545	CcSEcCtD
Prednisone—Rash—Methotrexate—colon cancer	3.69e-05	0.00054	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—colon cancer	3.68e-05	0.00054	CcSEcCtD
Prednisone—Headache—Methotrexate—colon cancer	3.66e-05	0.000537	CcSEcCtD
Prednisone—Nausea—Methotrexate—colon cancer	3.47e-05	0.000509	CcSEcCtD
